This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Centaurus Biopharma Co., Ltd., Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Lianyungang Runzhong Pharmaceutical Co., Ltd.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: The Innovations of Shan Zhou
Introduction
Shan Zhou is a notable inventor based in Lianyungang, China. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative patent. His work focuses on enhancing the stability and bioavailability of pharmaceutical compositions.
Latest Patents
Shan Zhou holds a patent for a solid pharmaceutical composition containing a 1,3,5-triazine derivative or a pharmaceutically acceptable salt thereof. This composition includes 4-(tert-butoxyamino)-6-(6-(trifluoromethyl)pyridin-2-yl)-N-(2-(trifluoromethyl)pyridin-4-yl)-1,3,5-triazine-2-amine. The preparation method for this composition ensures good stability, a fast dissolution rate, and high bioavailability, making it suitable for clinical production and use.
Career Highlights
Throughout his career, Shan Zhou has worked with prominent companies in the pharmaceutical industry. He has been associated with Chia Tai Tianqing Pharmaceutical Group Co., Ltd. and Lianyungang Runzhong Pharmaceutical Co., Ltd. His experience in these organizations has contributed to his expertise in developing innovative pharmaceutical solutions.
Collaborations
Shan Zhou has collaborated with talented individuals in his field, including Yuanyuan Sun and Lei Liu. These partnerships have fostered a collaborative environment that encourages innovation and the advancement of pharmaceutical research.
Conclusion
Shan Zhou's contributions to the pharmaceutical industry through his innovative patent demonstrate his commitment to improving drug formulations. His work not only enhances the effectiveness of medications but also paves the way for future advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile